1. Micro-RNA miR-542-3p suppresses decidualization by targeting ILK pathways in human endometrial stromal cells
    Xinlan Qu et al, 2021, Scientific Reports CrossRef
  2. miR-542-3p suppresses invasion and metastasis by targeting the proto-oncogene serine/threonine protein kinase, PIM1, in melanoma
    Zhen Rang et al, 2016, Biochemical and Biophysical Research Communications CrossRef
  3. MicroRNA-542-3p inhibits the growth of hepatocellular carcinoma cells by targeting FZD7/Wnt signaling pathway
    Wenhua Wu et al, 2017, Biochemical and Biophysical Research Communications CrossRef
  4. miR-182 suppresses invadopodia formation and metastasis in non-small cell lung cancer by targeting cortactin gene
    Yongwen Li et al, 2018, Journal of Experimental & Clinical Cancer Research CrossRef
  5. Formononetin exhibits anticancer activity in gastric carcinoma cell and regulatingmiR‐542‐5p
    Wei‐Song Wang et al, 2021, The Kaohsiung Journal of Medical Sciences CrossRef
  6. Integrative Transcriptomic Network Analysis of Butyrate Treated Colorectal Cancer Cells
    Saira R. Ali et al, 2021, Cancers CrossRef
  7. Astrocyte elevated gene-1 serves as a target of miR542 to promote glioblastoma proliferation and invasion
    Chong Li et al, 2020, Chinese Medical Journal CrossRef
  8. miR‐542‐3p prevents ovariectomy‐induced osteoporosis in rats via targeting SFRP1
    Xiguang Zhang et al, 2018, Journal of Cellular Physiology CrossRef
  9. MicroRNA-130a is upregulated in colorectal cancer and promotes cell growth and motility by directly targeting forkhead box F2
    Wenzhong Chen et al, 2017, Molecular Medicine Reports CrossRef
  10. Cortactin function in invadopodia
    Pauline Jeannot et al, 2020, Small GTPases CrossRef
  11. microRNAs expression profile related with response to preoperative radiochemotherapy in patients with locally advanced gastric cancer
    Xiaowen Liu et al, 2018, BMC Cancer CrossRef
  12. MicroRNA-337 inhibits colorectal cancer progression by directly targeting KRAS and suppressing the AKT and ERK pathways
    Xuerong Liu et al, 2017, Oncology Reports CrossRef
  13. MicroRNAs miR-19, miR-340, miR-374 and miR-542 regulate MID1 protein expression
    Kristoffer Unterbruner et al, 2018, PLOS ONE CrossRef
  14. Exosomal miRNAs species in the blood of small cell and non-small cell lung cancer patients
    Valeriy Poroyko et al, 2018, Oncotarget CrossRef
  15. Six-gene signature for predicting survival in patients with head and neck squamous cell carcinoma
    Juncheng Wang et al, 2020, Aging CrossRef
  16. Long noncoding RNA TUG1 regulates the progression of colorectal cancer through miR-542-3p/TRIB2 axis and Wnt/β-catenin pathway
    Quanlin Liu et al, 2021, Diagnostic Pathology CrossRef
  17. MicroRNAs: Important Players in Breast Cancer Angiogenesis and Therapeutic Targets
    Bashdar Mahmud Hussen et al, 2021, Frontiers in Molecular Biosciences CrossRef
  18. MiR-182 Inhibition Protects Against Experimental Stroke in vivo and Mitigates Astrocyte Injury and Inflammation in vitro via Modulation of Cortactin Activity
    Qasim M. Alhadidi et al, 2022, Neurochemical Research CrossRef
  19. Survivin-targeting miR-542-3p overcomes HER3 signaling-induced chemoresistance and enhances the antitumor activity of paclitaxel against HER2-overexpressing breast cancer
    Hui Lyu et al, 2018, Cancer Letters CrossRef
  20. Silencing LncRNA CASC9 inhibits proliferation and invasion of colorectal cancer cells by MiR-542-3p/ILK
    Heping Zhang et al, 2022, PLOS ONE CrossRef
  21. miR-542-3p Contributes to the HK2-Mediated High Glycolytic Phenotype in Human Glioma Cells
    Junhyung Kim et al, 2021, Genes CrossRef
  22. LncRNA INPP5F ameliorates stress‐induced hypertension via the miR‐335/Cttn axis in rostral ventrolateral medulla
    Shuai Zhang et al, 2023, CNS Neuroscience & Therapeutics CrossRef
  23. MiR-542-3p exerts tumor suppressive functions in non-small cell lung cancer cells by upregulating FTSJ2
    Bin Liu et al, 2017, Life Sciences CrossRef
  24. Cortactin and phosphorylated cortactin tyr 466 expression in temporal bone carcinoma
    Gino Marioni et al, 2017, American Journal of Otolaryngology CrossRef